This indicates that GBM tumors acquire drug resistance by initiating ABC transporter expression immediately as a means of survival against exposed xenobiotic molecules, which emphasizes the role of ABC transporters in conferring MDR. This evidence concerns the gene ABCG2 and glioblastoma.